10 Top Drugs Now or Soon With Generic Equivalents

Overall spending on traditional prescription drugs -- mostly pills used to treat common conditions such as high cholesterol and depression -- will decline 4% by the end of 2015, largely because of the availability of generic medications, according Express Scripts. Here are 10 of the top brand-name d

Author
HDM Staff
Save
Share



    Cymbalta

    Used for: Depression

    Manufactured by: Lilly

    Estimated annual sales: $4.7 billion

    Generic: duloxetine

    Generic launch date: December 2013


    Lidoderm 5%

    Used for: Skin conditions

    Manufactured by: Endo

    Estimated annual sales: $1.3 billion

    Generic: lidocaine topical patch

    Generic launch date: September 2013


    Niaspan

    Used for: High blood cholesterol

    Manufactured by: AbbVie

    Estimated annual sales: $1.2 billion

    Generic: niacin, extended release

    Generic launch date: September 2013


    AcipHex

    Used for: Ulcer disease

    Manufactured by: Eisai

    Estimated annual sales: $901 million

    Generic: rabeprazole

    Generic launch date: November 2013


    Suboxone Sublingual Tablets

    Used for: Pain

    Manufactured by: Reckitt Benkiser

    Estimated annual sales: $697 million

    Generic: buprenorphine/naloxone

    Generic launch date: February 2013


    Nexium

    Used for: Ulcer disease

    Manufactured by: AstraZeneca

    Estimated annual sales: $6.1 billion

    Generic: esomeprazole

    Generic launch date: May 2014


    Copaxone 20 mg/mL

    Used for: Mental/neurological disorders

    Manufactured by: Teva

    Estimated annual sales: $3.7 billion

    Generic: glatiramer acetate

    Generic launch date: May 2014


    Diovan

    Used for: High blood pressure/heart disease

    Manufactured by: Novartis

    Estimated annual sales $2.1 billion

    Generic: valsartan

    Generic launch date: Mid-2014


    Renvela

    Used for: Gastrointestinal disorders

    Manufactured by: Genzyme

    Estimated annual sales: $889 million

    Generic: sevelamer carbonate

    Generic launch date: March 2014


    Lunesta

    Used for: Sleep disorders

    Manufactured by: Sunovion

    Estimated annual sales: $852 million

    Generic: eszopiclone

    Generic launch date: April 2014